Umbilical & Placental Cell News Volume 16.07 | Feb 22 2024

    0
    7








    2024-02-22 | UPCN 16.07


    Umbilical-and-Placental-Cell-News-email-header (1)
    Vol. 16.07 – 22 February, 2024
    TOP STORY

    Targeting Senescent Alveolar Epithelial Cells Using Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Pulmonary Fibrosis

    Investigators constructed CD38 antigen receptor membrane-modified MSC-extracellular vesicles by transfecting MSCs with a lentivirus loaded with a CD38 antigen receptor–CD8 transmembrane fragment fusion plasmid to target AEC2s and alleviate pulmonary fibrosis.
    [ACS Nano]

    AbstractGraphical Abstract

    Standardize Your Spheroid Production With AggreWell™ Microwell Plates
    PUBLICATIONSRanked by the impact factor of the journal

    Single-Cell Assessment of Primary and Stem Cell-Derived Human Trophoblast Organoids as Placenta-Modeling Platforms

    Using single-cell transcriptomics, scientists evaluated how organoids derived from freshly isolated first-trimester trophoblasts or from established human trophoblast stem cell lines reproduce developmental cell trajectories and transcriptional regulatory processes defined in vivo.
    [Developmental Cell]

    AbstractGraphical Abstract

    Placental Transfer Dynamics and Durability of Maternal COVID-19 Vaccine-Induced Antibodies in Infants

    The authors evaluated anti-COVID antibody IgG subclass, Fc-receptor binding profile, and activity against wild-type Spike and RBD plus five variants of concern in 153 serum samples from 100 infants.
    [iScience]

    AbstractGraphical Abstract

    Human Archetypal Pluripotent Stem Cells Differentiate into Trophoblast Stem Cells via Endogenous BMP5/7 Induction without Transitioning through Naive State

    Researchers demonstrated that the primed pluripotent state can generate trophoblast stem cells by activating pathways such as EGF and WNT, and by suppressing TGFβ, HDACs, and Rho-associated protein kinase signaling pathways, all without the addition of exogenous Bone morphogenetic protein 4.
    [Scientific Reports]

    Full Article

    Establishment and Comparison of Human Term Placenta-Derived Trophoblast Cells

    Investigators described the development of a human-term placenta-derived cytotrophoblast immortalized cell line (hPTCCTB) derived from the basal plate. hPTCCTB cells were comparable to their primary cells of origin in terms of morphology, marker expression, and functional responses.
    [Biology Of Reproduction]

    Abstract
    Graphical Abstract

    The Effect of Wharton’s Jelly-Derived Stem Cells Seeded/Boron-Loaded Acellular Scaffolds on the Healing of Full-Thickness Burn Wounds in the Rat Model

    A new regenerative platform based on boron enriched-acellular sheep small intestine submucosa scaffold was designed and used as a carrier for mesenchymal stem cells derived from Wharton’s jelly aiming to promote the tissue healing in burn-induced rat models.
    [Biomedical Materials]

    Abstract

    Novel Therapeutic Targets, Including IGFBP3, of Umbilical Cord Mesenchymal Stem-Cell-Conditioned Medium in Intrauterine Adhesion

    Umbilical cord MSC-conditioned medium produced positive effects on a transforming growth factor beta-induced intrauterine adhesion cell model.
    [Biology Open]

    Full Article
    Get a Head Start with Our New Lab Start-Up Program
    REVIEWS

    Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cell Therapy in Preclinical Models of Sepsis: A Systematic Review and Meta-Analysis

    The authors examine the effects of UC-MSCs on overall mortality as well as on organ dysfunction, coagulopathy, endothelial permeability, pathogen clearance, and systemic inflammation at prespecified time intervals in preclinical models of sepsis.
    [Stem Cells Translational Medicine]

    Full Article

    Conserved and Divergent Features of Trophoblast Stem Cells

    Scientists summarize the establishment and maintenance of trophoblast stem cells in mammals and nontraditional animal models with a primary emphasis on epigenetic regulation of their origin while defining gaps in the current literature and areas of further development.
    [Journal Of Molecular Endocrinology]

    Abstract
    INDUSTRY AND POLICY NEWS

    Cellenkos’ ALS Cell Therapy Clinical Trial Progresses to Next Phase

    Cellenkos has received approval to advance to the second cohort of patients in its clinical trial of neurotrophic T regulatory cell therapy CK0803 for ALS treatment.
    [Clinical Trials Arena]

    Press Release

    Alberta Couple Raises Contamination Concerns as Health Canada Cracks Down on Cord Blood Clinic

    three months after Health Canada issued a public health warning about the Canadian Cord Blood bioRepository facility in west Edmonton, a local couple no longer trusts that the potentially life-saving stem cells they have spent thousands of dollars to preserve remain viable or safe.
    [CBC]

    Editorial
    FEATURED EVENT

    46th JSTCT Annual Meeting (JSTCT2024) Japanese Society for Transplantation and Cellular Therapy

    March 21 – 23, 2024
    Tokyo, Japan

    > See All Events

    JOB OPPORTUNITIES

    Research Associate – Malarial Damage in the Placenta

    University of Alberta – Edmonton, Alberta, Canada

    Postdoctoral Researcher – Placenta-Brain Axis

    University of Amsterdam – Amsterdam, Netherlands

    Postdoctoral Position – Red Blood Cell Signaling and Physiology

    University of Maryland Baltimore – Baltimore, Maryland, United States

    Faculty Positions – Obstetrics, Gynecology and Reproductive Health

    Rutgers, New Jersey Medical School – Newark, New Jersey, United States

    Research Associate – Maternal & Fetal Health

    The University of Manchester – Manchester, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2